TheFly.com
Start Free Trial
<
Back to all Breaking News
MRSN
8/11/2017 07:08am
3
Street Research Stories
1
Calendar Events
chevron_right
Mersana Therapeutics reports Q2 EPS ($6.33), may not compare to consensus (69c)
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.
Join Now
Learn More
Already have an account?
Sign In Here
Subscription Rates
dynamic_feed
Breaking News
search
Search
menu
Menu
